Pharmaceutical case processing is witnessing a 15% annual increase in adverse event reports, according to FDA statistics. Over the last decade the industry has exhausted resourcing to low-cost ...

Pharmaceutical and biopharma companies are required by regulatory compulsions to implement a pharmacovigilance/drug safety surveillance programme and monitor the safety profiles of their marketed ...

On August 1, 2016, the U.S. Department of Labor (DOL) launched a new pilot program, titled “Expedited Case Processing Pilot,” in its Western region. Here is the DOL’s press release describing the ...

Case management, no matter the type of case, provides an opportunity for a productivity-clogging backlog. You have a pipeline into which new cases are entered while current cases remain open in ...